Drug Type Oligonucleotide |
Synonyms RCT-223 |
Target |
Mechanism CFTR gene modulators |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cystic Fibrosis | Preclinical | US | ReCode Therapeutics, Inc.Startup | 21 Oct 2021 |
Cystic Fibrosis | Preclinical | US | 21 Oct 2021 |